A noninvasive treatment using light and sound shown to trigger the brain’s natural waste-clearance system to combat Alzheimer's disease. More than 7 million Americans are currently living with Alzheimer’s disease, a crisis projected to cost the U.S. healthcare system an estimated $409 billion in 2026. This treatment could change that. In a groundbreaking preclinical study funded by the National Institute on Aging (NIA), researchers from MIT, Boston University, and Westlake University in China have discovered that noninvasive light and sound stimulation can significantly reduce levels of toxic amyloid proteins in the brain. By exposing mice to flashing lights and auditory tones engineered to generate 40-hertz electrical gamma waves, scientists triggered a dramatic boost in the flow of cerebrospinal fluid. This sensory stimulation effectively tapped into the brain’s glymphatic system—its internal waste-disposal network—prompting cells called astrocytes to expand, flush out debris, and clear the destructive plaques historically associated with Alzheimer’s disease. The therapeutic mechanism relies on a delicate chain reaction in the brain. Researchers found that gamma wave stimulation coaxes specific inhibitory interneurons to release a vital hormone called vasoactive intestinal peptide (VIP). This hormone signals the glymphatic system to increase fluid circulation, accelerating the elimination of toxic waste. When scientists experimentally blocked either the astrocytes' expansion or the interneurons' ability to produce VIP, the plaque-clearing benefits vanished. These promising results suggest that simple, noninvasive sensory therapy could act as a potent tool to keep our brain's plumbing running smoothly, offering a highly accessible avenue for treating Alzheimer’s and other protein-accumulating neurological disorders. source: Murdock, M. H., et al. Multisensory gamma stimulation promotes glymphatic clearance of amyloid. Nature, 627(8002), 149-156.